PCR amplification followed by sequencing identified an additional MLLT1 p.117_118insNHL mutation in 1/19 tumours originally characterized by WES, for a total of 7 MLLT1 mutations in 77 discovery set tumours (11%) (Supplementary Table 1). This evidence concerns the gene MLLT1 and neoplasm.